Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells

Table 4

Liver fibrosis staging of two groups before and after treatment (according to the criteria of Scheuer’s classification).

	NAs group		NAs + FZHY group
n	Pre	Post	Pre	Post
S1	0 (0%)	0 (0%)	0 (0%)	0 (0%)
S2	2 (25%)	0 (0%)	2 (16.7%)	2 (16.7%)
S3	4 (50%)	3 (37.5%)	7 (58.3%)	8 (66.7%)
S4	2 (25%)	5 (62.5%)	3 (25%)	2 (16.7%)
Total	8	8	12	12

versus the Post S4 of NAs group; S, stage of liver fibrosis (S0–S4).